中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2012年
6期
1040-1042
,共3页
齐进春%王晓路%蔡文清%黎玮%李丽%张艳平%郭垣杉
齊進春%王曉路%蔡文清%黎瑋%李麗%張豔平%郭垣杉
제진춘%왕효로%채문청%려위%리려%장염평%곽원삼
前列腺癌%基因治疗%重组腺病毒%端粒酶逆转录酶
前列腺癌%基因治療%重組腺病毒%耑粒酶逆轉錄酶
전렬선암%기인치료%중조선병독%단립매역전록매
Prostate cancer%Gene therapy%Recombinant adenovirus%Telomerase reverse transcriptase
目的 观察野甘草醇(SDC)在人端粒酶逆转录酶(hTERT)启动子调控腺病毒介导的单纯疱疹病毒胸腺激酶基因/更昔洛韦(HSV-tk/GCV)自杀基因系统对人前列腺癌细胞的杀伤作用中的增效作用.方法 测定胸苷激酶(TK)活性,应用高效液相色谱( HPLC)法测定三磷酸更昔洛韦(GCV-TP)在肿瘤细胞内的浓度,将不同配伍浓度的SDC、Ad-hTERT-HSV-tk、更昔洛韦(GCV)应用于前列腺癌细胞,观察体外对前列腺癌细胞的杀伤作用、旁杀伤效应.结果 SDC对转染Ad-hTERT-HSV-tk的LNCaP、PC3细胞的TK酶活性影响不明显.应用高效液相色谱法分析,以单加GCV组的GCV-TP浓度计作100%.在加入0.04μmolSDC后,GCV-TP浓度与不加SDC比较提高到(101.0±1.5)%,但差异无统计学意义(P>0.05);加入5倍治疗剂量0.20 μmol SDC后,GCV-TP浓度提高到(106.0±4.5)%,差异有统计学意义(P<0.05).并进一步通过细胞实验证实,SDC对Ad-hTERT-HSV-tk+ GCV杀伤前列腺癌细胞无明显增效作用,但是旁杀伤效应增加明显.结论 SDC对胸腺激酶依赖的GCV阻断前列腺癌进展有一定的增效作用,将天然药物SDC与我们构建的具有肿瘤特异性的重组腺病毒Ad-hTERT-HSV-tk以及GCV联合应用,可以达到增效减毒的目的.
目的 觀察野甘草醇(SDC)在人耑粒酶逆轉錄酶(hTERT)啟動子調控腺病毒介導的單純皰疹病毒胸腺激酶基因/更昔洛韋(HSV-tk/GCV)自殺基因繫統對人前列腺癌細胞的殺傷作用中的增效作用.方法 測定胸苷激酶(TK)活性,應用高效液相色譜( HPLC)法測定三燐痠更昔洛韋(GCV-TP)在腫瘤細胞內的濃度,將不同配伍濃度的SDC、Ad-hTERT-HSV-tk、更昔洛韋(GCV)應用于前列腺癌細胞,觀察體外對前列腺癌細胞的殺傷作用、徬殺傷效應.結果 SDC對轉染Ad-hTERT-HSV-tk的LNCaP、PC3細胞的TK酶活性影響不明顯.應用高效液相色譜法分析,以單加GCV組的GCV-TP濃度計作100%.在加入0.04μmolSDC後,GCV-TP濃度與不加SDC比較提高到(101.0±1.5)%,但差異無統計學意義(P>0.05);加入5倍治療劑量0.20 μmol SDC後,GCV-TP濃度提高到(106.0±4.5)%,差異有統計學意義(P<0.05).併進一步通過細胞實驗證實,SDC對Ad-hTERT-HSV-tk+ GCV殺傷前列腺癌細胞無明顯增效作用,但是徬殺傷效應增加明顯.結論 SDC對胸腺激酶依賴的GCV阻斷前列腺癌進展有一定的增效作用,將天然藥物SDC與我們構建的具有腫瘤特異性的重組腺病毒Ad-hTERT-HSV-tk以及GCV聯閤應用,可以達到增效減毒的目的.
목적 관찰야감초순(SDC)재인단립매역전록매(hTERT)계동자조공선병독개도적단순포진병독흉선격매기인/경석락위(HSV-tk/GCV)자살기인계통대인전렬선암세포적살상작용중적증효작용.방법 측정흉감격매(TK)활성,응용고효액상색보( HPLC)법측정삼린산경석락위(GCV-TP)재종류세포내적농도,장불동배오농도적SDC、Ad-hTERT-HSV-tk、경석락위(GCV)응용우전렬선암세포,관찰체외대전렬선암세포적살상작용、방살상효응.결과 SDC대전염Ad-hTERT-HSV-tk적LNCaP、PC3세포적TK매활성영향불명현.응용고효액상색보법분석,이단가GCV조적GCV-TP농도계작100%.재가입0.04μmolSDC후,GCV-TP농도여불가SDC비교제고도(101.0±1.5)%,단차이무통계학의의(P>0.05);가입5배치료제량0.20 μmol SDC후,GCV-TP농도제고도(106.0±4.5)%,차이유통계학의의(P<0.05).병진일보통과세포실험증실,SDC대Ad-hTERT-HSV-tk+ GCV살상전렬선암세포무명현증효작용,단시방살상효응증가명현.결론 SDC대흉선격매의뢰적GCV조단전렬선암진전유일정적증효작용,장천연약물SDC여아문구건적구유종류특이성적중조선병독Ad-hTERT-HSV-tk이급GCV연합응용,가이체도증효감독적목적.
Objective To investigate the synergistic efect of scopadulciol (SDC) on the killing effect on antitumor actions by Ad-hTERT-HSV-tk/ganciclovir (GCV) suicide gene system on prostate cancer cells in vitro.Methods To clarify the mechanism of enhanced effect of SDC in the gene therapy of human prostate cancer by TK-dependent GCV in molecular level,the TK enzyme activity and the concentration of GCV-TP in the tumor cells were measured by using high performance liquid chromatography (HPLC).The prostate cancer cells,respectively,were treated with Ad-hTERT-HSV-tk or GCV in combination with SDC with different doses and different concentrations.The killing effect and the bystander effect of these drugs in the therapy of human prostate cancer cells were observed.Results SDC had slightly effect on the TK enzyme activity of LNCaP and PC3 cells that were transduced by Ad-hTERT-HSV-tk.The GCV-TP concentration in the GCV treatment group was 100%.The GCV-TP concentration was ( 101.0 ± 1.5) % when 0.04 μmol/L SDC was added,but there was no significant difference.The GCV-TP concentration was up to ( 106.0 ± 4.5) % when adding 0.20 μmol/L SDC that was 5-fold higher for the dose of the therapy,and there was significant difference campared to the GCV treatment group (P<0.05).It was confirmed that SDC had strong bystander effect and weak killing effect on the prostate cancer cells by conbination of Ad-hTERT-HSV-tk and GCV.Conclusion The synergistic effect of SDC is significantly shown in the therapy of human prostate cancer cells by TK-dependent GCV.SDC is effective in the Ad-hTERT-HSV-tk/GCV administration system in killing prostate cancer cells.